Methylation Based Classification of Human Tumors

Thursday, November 16, 2023

5:00 PM - 6:00 PM MST

Speaker(s)

Andreas von Deimling, MD (he/him/his)

Director Dept Neuropathology (University Hospital Heidelberg), and director CCU Neuropathology (DKFZ)
Dept Neuropathology University Hospital Heidelberg, CCU Neuropathology, German Cancer Center DKFZ
Heidelberg, Baden-Wurttemberg, Germany

Session Description: The session will provide an introduction into the biological and biomathematical principles of methylation-based classifiers using the example of the brain tumor classifier. It will demonstrate the progress of expanding this approach to other tumor groups such as sarcomas and carcinomas. The strengths and weaknesses of classifiers will be discussed.

If this session topic is of interest to you, please consider looking at the following course on AMP EDucation (AMPED™ Online)

Title: DNA Methylation Profiling in Clinical Diagnostics of Brain Tumors
Click here to learn more.

Learning Objectives:

Gaining insight into the methylation-based classification approach.
Assessing pros and cons of employing this method.
Experiencing encouragement for testing and critically interrogating novel diagnostic approaches